TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s technologies are designed to overcome primary and acquired resistance to checkpoint inhibitors or cellular therapies in the treatment of cancer.
Company Details
- Employees
- 24
- Founded
- -
- Address
- 10500 University Center Dr,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://tuhurabio.com
- Keywords
- jobs.
- HQ
- Tampa, Florida
Tuhura Biosciences, Inc. Questions
Tuhura Biosciences, Inc.'s website is https://tuhurabio.com
Tuhura Biosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/tuhurabio
Tuhura Biosciences, Inc. has
24 employees.
View email and phone details for 24
employees at Tuhura Biosciences, Inc..
Tuhura Biosciences, Inc.'s industry is
Biotechnology Research
Tuhura Biosciences, Inc.'s top competitors are
Kineta,
Kintara Therapeutics, Inc. Nasdaq: Ktra,
Amd Bio,
Cellectis,
Abceutics Inc.,
Macrogenics, Inc.,
Svax,
Zentalis Pharmaceuticals,
Kartos Therapeutics, Inc.,
Tuhura Biosciences.
Tuhura Biosciences, Inc.'s categories are Biotechnology Research
Tuhura Biosciences, Inc.'s founding year is 1996
